NFX1
From Wikipedia, the free encyclopedia
Nuclear transcription factor, X-box binding 1
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | NFX1; DKFZp779G2416; MGC20369; NFX2 | |||||||||||||
External IDs | OMIM: 603255 MGI: 1921414 HomoloGene: 1875 | |||||||||||||
|
||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 4799 | 74164 | ||||||||||||
Ensembl | ENSG00000086102 | ENSMUSG00000028423 | ||||||||||||
Uniprot | Q12986 | n/a | ||||||||||||
Refseq | NM_002504 (mRNA) NP_002495 (protein) |
NM_023739 (mRNA) NP_076228 (protein) |
||||||||||||
Location | Chr 9: 33.28 - 33.36 Mb | Chr 4: 41.16 - 41.21 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Nuclear transcription factor, X-box binding 1, also known as NFX1, is a human gene.[1]
MHC class II gene expression is controlled primarily at the transcriptional level by transcription factors that bind to the X and Y boxes, two highly conserved elements in the proximal promoter of MHC class II genes. The protein encoded by this gene is a transcriptional repressor capable of binding to the conserved X box motif of HLA-DRA and other MHC class II genes in vitro. The protein may play a role in regulating the duration of an inflammatory response by limiting the period in which class II MHC molecules are induced by IFN-gamma. Three alternative splice variants, each of which encodes a different isoform, have been identified.[1]
[edit] References
[edit] Further reading
- Hume CR, Lee JS (1990). "Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors.". Hum. Immunol. 26 (4): 288–309. PMID 2511169.
- Song Z, Krishna S, Thanos D, et al. (1994). "A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor.". J. Exp. Med. 180 (5): 1763–74. PMID 7964459.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. PMID 9373149.
- Lorick KL, Jensen JP, Fang S, et al. (1999). "RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.". Proc. Natl. Acad. Sci. U.S.A. 96 (20): 11364–9. PMID 10500182.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi: . PMID 14702039.
- Saito K, Fujiwara T, Katahira J, et al. (2004). "TAP/NXF1, the primary mRNA export receptor, specifically interacts with a neuronal RNA-binding protein HuD.". Biochem. Biophys. Res. Commun. 321 (2): 291–7. doi: . PMID 15358174.
- Gewin L, Myers H, Kiyono T, Galloway DA (2004). "Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex.". Genes Dev. 18 (18): 2269–82. doi: . PMID 15371341.
- Katzenellenbogen RA, Egelkrout EM, Vliet-Gregg P, et al. (2007). "NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.". J. Virol. 81 (8): 3786–96. doi: . PMID 17267499.